Cencora Net Profit Margin 2010-2025 | COR
Current and historical net profit margin for Cencora (COR) from 2010 to 2025. Net profit margin can be defined as net Income as a portion of total sales revenue. Cencora net profit margin for the three months ending March 31, 2025 was .
| Cencora Net Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Net Income | Net Margin |
| 2025-03-31 | $310.23B | $1.69B | 0.55% |
| 2024-12-31 | $303.19B | $1.40B | 0.46% |
| 2024-09-30 | $293.96B | $1.51B | 0.51% |
| 2024-06-30 | $283.83B | $1.86B | 0.65% |
| 2024-03-31 | $276.54B | $1.85B | 0.67% |
| 2023-12-31 | $271.58B | $1.87B | 0.69% |
| 2023-09-30 | $262.17B | $1.75B | 0.67% |
| 2023-06-30 | $254.43B | $1.69B | 0.66% |
| 2023-03-31 | $247.54B | $1.62B | 0.65% |
| 2022-12-31 | $241.81B | $1.73B | 0.72% |
| 2022-09-30 | $238.59B | $1.70B | 0.71% |
| 2022-06-30 | $236.33B | $1.84B | 0.78% |
| 2022-03-31 | $229.67B | $1.73B | 0.75% |
| 2021-12-31 | $221.10B | $1.61B | 0.73% |
| 2021-09-30 | $213.99B | $1.54B | 0.72% |
| 2021-06-30 | $204.32B | $-3.74B | -1.83% |
| 2021-03-31 | $196.28B | $-3.75B | -1.91% |
| 2020-12-31 | $194.55B | $-3.22B | -1.66% |
| 2020-09-30 | $189.90B | $-3.41B | -1.80% |
| 2020-06-30 | $186.29B | $1.57B | 0.84% |
| 2020-03-31 | $186.16B | $1.58B | 0.85% |
| 2019-12-31 | $182.06B | $0.65B | 0.36% |
| 2019-09-30 | $179.59B | $0.86B | 0.48% |
| 2019-06-30 | $177.25B | $0.96B | 0.54% |
| 2019-03-31 | $175.15B | $0.93B | 0.53% |
| 2018-12-31 | $172.87B | $1.19B | 0.69% |
| 2018-09-30 | $167.94B | $1.66B | 0.99% |
| 2018-06-30 | $163.76B | $1.08B | 0.66% |
| 2018-03-31 | $159.33B | $0.85B | 0.54% |
| 2017-12-31 | $155.44B | $0.98B | 0.63% |
| 2017-09-30 | $153.14B | $0.36B | 0.24% |
| 2017-06-30 | $151.58B | $0.85B | 0.56% |
| 2017-03-31 | $149.76B | $1.15B | 0.77% |
| 2016-12-31 | $148.31B | $1.35B | 0.91% |
| 2016-09-30 | $146.85B | $1.43B | 0.97% |
| 2016-06-30 | $144.76B | $1.64B | 1.13% |
| 2016-03-31 | $142.11B | $1.51B | 1.06% |
| 2015-12-31 | $139.08B | $0.39B | 0.28% |
| 2015-09-30 | $135.96B | $-0.14B | -0.10% |
| 2015-06-30 | $132.08B | $-0.43B | -0.33% |
| 2015-03-31 | $128.20B | $-0.66B | -0.51% |
| 2014-12-31 | $123.98B | $0.03B | 0.03% |
| 2014-09-30 | $119.57B | $0.27B | 0.23% |
| 2014-06-30 | $112.45B | $0.26B | 0.23% |
| 2014-03-31 | $104.01B | $0.44B | 0.42% |
| 2013-12-31 | $96.08B | $0.31B | 0.32% |
| 2013-09-30 | $87.96B | $0.43B | 0.49% |
| 2013-06-30 | $82.23B | $0.55B | 0.66% |
| 2013-03-31 | $79.65B | $0.56B | 0.70% |
| 2012-12-31 | $78.83B | $0.73B | 0.92% |
| 2012-09-30 | $78.08B | $0.72B | 0.92% |
| 2012-06-30 | $78.23B | $0.70B | 0.90% |
| 2012-03-31 | $79.07B | $0.71B | 0.89% |
| 2011-12-31 | $79.12B | $0.71B | 0.89% |
| 2011-09-30 | $78.70B | $0.71B | 0.90% |
| 2011-06-30 | $79.35B | $0.70B | 0.88% |
| 2011-03-31 | $78.79B | $0.68B | 0.86% |
| 2010-12-31 | $78.33B | $0.65B | 0.82% |
| 2010-09-30 | $77.78B | $0.64B | 0.82% |
| 2010-06-30 | $76.96B | $0.63B | 0.81% |
| 2010-03-31 | $75.75B | $0.58B | 0.77% |
| 2009-12-31 | $73.76B | $0.54B | 0.74% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $56.449B | $293.959B |
| CENCORA INC is a healthcare solutions provider. CENCORA INC., formerly known as AmerisourceBergen, is based in CONSHOHOCKEN, Pa. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $135.906B | 25.49 |
| Elevance Health (ELV) | United States | $86.723B | 11.19 |
| CVS Health (CVS) | United States | $81.012B | 10.07 |
| DiDi Global (DIDIY) | China | $21.556B | 32.71 |
| Natera (NTRA) | United States | $21.537B | 0.00 |
| BioMerieux (BMXMF) | France | $15.890B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $12.928B | 0.00 |
| Solventum (SOLV) | United States | $12.646B | 13.39 |
| CochLear (CHEOY) | Australia | $11.378B | 0.00 |
| Revvity (RVTY) | United States | $10.658B | 18.34 |
| ICON (ICLR) | Ireland | $10.521B | 9.78 |
| Viatris (VTRS) | United States | $10.317B | 3.54 |
| Doximity (DOCS) | United States | $9.784B | 45.30 |
| Avantor (AVTR) | United States | $8.797B | 12.78 |
| HealthEquity (HQY) | United States | $8.702B | 42.81 |
| Medpace Holdings (MEDP) | United States | $8.476B | 22.51 |
| Sonic Healthcare (SKHHY) | Australia | $8.311B | 0.00 |
| Charles River Laboratories (CRL) | United States | $6.662B | 13.05 |
| Amplifon S.p.A (AMFPF) | Italy | $4.966B | 27.18 |
| BrightSpring Health Services (BTSG) | United States | $4.149B | 38.40 |
| Bausch + Lomb (BLCO) | Canada | $4.054B | 23.90 |
| Sotera Health (SHC) | United States | $3.474B | 19.74 |
| Alignment Healthcare (ALHC) | United States | $3.041B | 0.00 |
| Surgery Partners (SGRY) | United States | $3.026B | 39.35 |
| Concentras Parent (CON) | United States | $2.772B | 16.02 |
| Organon (OGN) | United States | $2.397B | 2.55 |
| Ardent Health Partners (ARDT) | United States | $2.071B | 8.83 |
| GeneDx Holdings (WGS) | United States | $2.032B | 78.26 |
| Premier (PINC) | United States | $1.892B | 14.36 |
| Progyny (PGNY) | United States | $1.843B | 40.57 |
| PACS (PACS) | United States | $1.512B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.400B | 28.00 |
| Pediatrix Medical (MD) | United States | $1.216B | 9.25 |
| Teladoc Health (TDOC) | United States | $1.214B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.011B | 0.00 |
| Establishment Labs Holdings (ESTA) | $0.995B | 0.00 | |
| CareDx (CDNA) | United States | $0.946B | 14.77 |
| Nutex Health (NUTX) | United States | $0.934B | 14.11 |
| Agilon Health (AGL) | United States | $0.919B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.848B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.808B | 7.57 |
| Embecta (EMBC) | United States | $0.615B | 4.15 |
| LifeMD (LFMD) | United States | $0.555B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.552B | 0.00 |
| Enhabit (EHAB) | United States | $0.532B | 43.75 |
| SBC Medicals (SBC) | United States | $0.532B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.474B | 10.67 |
| Sonida Senior Living (SNDA) | United States | $0.460B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.389B | 0.00 |
| Oncology Institute (TOI) | United States | $0.285B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.240B | 0.00 |
| Beauty Health (SKIN) | United States | $0.205B | 0.00 |
| KindlyMD (KDLY) | United States | $0.150B | 0.00 |
| DocGo (DCGO) | United States | $0.145B | 23.67 |
| KindlyMD (NAKA) | United States | $0.136B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.112B | 0.00 |
| OncoCyte (OCX) | United States | $0.095B | 0.00 |
| So-Young (SY) | China | $0.087B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.067B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.059B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.058B | 0.00 |
| Biodesix (BDSX) | United States | $0.044B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.041B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.030B | 0.00 |
| ModivCare (MODV) | United States | $0.016B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.012B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.010B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.009B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.008B | 0.00 | |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| INVO Fertility (IVF) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |